Clinical Trial Update: REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults [Phase 3]

View source ↗

Summary

Regeneron is conducting a Phase 3 trial to compare REGN7508 to apixaban and enoxaparin for thromboprophylaxis after total knee arthroplasty; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)
• Lovenox (enoxaparin)
• REGN7508

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Venous Thromboembolism (VTE) | Phase 3 | Status: RECRUITING